These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22762424)

  • 41. Evaluation of the Genotype® MTBDRplus assay as a tool for drug resistance surveys.
    Rigouts L; Hoza AS; De Rijk P; Torrea G; Chonde TM; Basra D; Zignol M; van Leth F; Egwaga SM; Van Deun A
    Int J Tuberc Lung Dis; 2011 Jul; 15(7):959-65. PubMed ID: 21682972
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Redefining MDR-TB: Comparison of Mycobacterium tuberculosis clinical isolates from Russia and Taiwan.
    Jou R; Lee WT; Kulagina EV; Weng JY; Isakova AI; Lin WH; Antonova OV; Wu MH; Arslanbaeva LR; Tasi HY; Nosova EY; Zimenkov DV
    Infect Genet Evol; 2019 Aug; 72():141-146. PubMed ID: 30593924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis].
    Gui XH; Xu P; Zhao M; Wang LL; Wu J; Li J; Gao Q; Mei J
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jan; 33(1):43-5. PubMed ID: 20368024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surveillance and characterization of drug-resistant
    Imperiale BR; Di Giulio ÁB; Mancino MB; Zumárraga MJ; Morcillo NS
    Int J Mycobacteriol; 2019; 8(3):223-228. PubMed ID: 31512597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Susceptibilities of Mycobacterium tuberculosis to isoniazid and rifampin on blood agar.
    Coban AY; Bilgin K; Uzun M; Tasdelen Fisgin N; Akgunes A; Cihan CC; Birinci A; Durupinar B
    J Clin Microbiol; 2005 Apr; 43(4):1930-1. PubMed ID: 15815022
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
    Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
    Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam.
    Hung NV; Ando H; Thuy TT; Kuwahara T; Hang NT; Sakurada S; Thuong PH; Lien LT; Keicho N
    BMC Res Notes; 2013 Nov; 6():444. PubMed ID: 24188178
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid detection of multidrug-resistant Mycobacterium tuberculosis using the mycobacteria growth indicator tube (MGIT) system.
    Telles MA; Bori A; Amorim AB; Cruz AF; Pini MI; Sato DN
    Braz J Med Biol Res; 2002 Oct; 35(10):1127-31. PubMed ID: 12424483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concordance between molecular and phenotypic testing of Mycobacterium tuberculosis complex isolates for resistance to rifampin and isoniazid in the United States.
    Yakrus MA; Driscoll J; Lentz AJ; Sikes D; Hartline D; Metchock B; Starks AM
    J Clin Microbiol; 2014 Jun; 52(6):1932-7. PubMed ID: 24648563
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of Anyplex™ II MTB/MDR kit's performance to rapidly detect isoniazid and rifampicin resistant Mycobacterium tuberculosis from various clinical specimens.
    Chumpa N; Kawkitinarong K; Rotcheewaphan S; Sawatpanich A; Petsong S; Tumwasorn S; Suwanpimolkul G
    Mol Biol Rep; 2020 Apr; 47(4):2501-2508. PubMed ID: 32124172
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug Resistance Characteristics of
    Wu X; Yang J; Tan G; Liu H; Liu Y; Guo Y; Gao R; Wan B; Yu F
    Front Cell Infect Microbiol; 2019; 9():345. PubMed ID: 31828045
    [No Abstract]   [Full Text] [Related]  

  • 52. Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
    Johansen IS; Thomsen VØ; Marjamäki M; Sosnovskaja A; Lundgren B
    Diagn Microbiol Infect Dis; 2004 Oct; 50(2):103-7. PubMed ID: 15474318
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Using the Quantamatrix Multiplexed Assay Platform System.
    Wang HY; Uh Y; Kim S; Cho E; Lee JS; Lee H
    Ann Lab Med; 2018 Nov; 38(6):569-577. PubMed ID: 30027701
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.
    Blöndal K; Viiklepp P; Guðmundsson LJ; Altraja A
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1228-33. PubMed ID: 22748131
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison between the BACTEC MGIT 960 system and the agar proportion method for susceptibility testing of multidrug resistant tuberculosis strains in a high burden setting of South Africa.
    Said HM; Kock MM; Ismail NA; Baba K; Omar SV; Osman AG; Hoosen AA; Ehlers MM
    BMC Infect Dis; 2012 Dec; 12():369. PubMed ID: 23259765
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Isoniazid and rifampicin heteroresistant Mycobacterium tuberculosis isolated from tuberculous meningitis patients in India.
    Gupta R; Thakur R; Kushwaha S; Jalan N; Rawat P; Gupta P; Aggarwal A; Gupta M; Manchanda V
    Indian J Tuberc; 2018 Jan; 65(1):52-56. PubMed ID: 29332649
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-effectiveness of rapid susceptibility testing against second-line drugs for tuberculosis.
    Dowdy DW; van't Hoog A; Shah M; Cobelens F
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):647-54. PubMed ID: 24903933
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence Country.
    Ahmad S; Mokaddas E; Al-Mutairi N; Eldeen HS; Mohammadi S
    PLoS One; 2016; 11(4):e0153563. PubMed ID: 27096759
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran.
    Velayati AA; Masjedi MR; Farnia P; Tabarsi P; Ghanavi J; ZiaZarifi AH; Hoffner SE
    Chest; 2009 Aug; 136(2):420-425. PubMed ID: 19349380
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In-house, simple & economical phage technique for rapid detection of rifampicin, isoniazid, ethambutol, streptomycin & ciprofloxacin drug resistance using Mycobacterium tuberculosis isolates.
    Hemvani N; Patidar V; Chitnis DS
    Indian J Med Res; 2012 May; 135(5):783-7. PubMed ID: 22771613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.